CEO Roundtable

The CEO Roundtable series is an exclusive membership program that provides CEOs and executives from the bioscience and healthcare industry opportunities to network with like-minded leaders in a confidential, noncompeting environment. Members of the CEO Roundtable meet monthly in small groups where leaders dive into candid, deep, and thoughtful discussions about the unique hurdles faced by top-level management and get feedback from industry peers to make critical business decisions. The program is designed to help members run their companies more efficiently, expand and build a solid bond of trust and loyalty with key client executives, become more strategic, and create new growth opportunities. 

Annually, the CEO Roundtable is replaced by an evening event with a distinguished speaker, usually a leader in the industry with experience exiting a bioscience company. Through these events, members of the CEO Roundtable develop critical connections in the bioscience ecosystem and gather expert insights on managing a growth company.



To be considered for the CEO Roundtable, a business should meet the criteria described below.


Monthly Sessions | 8 – 9:30 a.m.

On the first or third Tuesday of the month, depending on assigned roundtable group.

2023 Bi-Annual Event
November 14, 2023


Exclusive membership limited availability! Members investment is $1,000 per year. VelocityTX Incubator program clients enjoy CEO Roundtable membership at 50% discount ($500).

Application and Selection Process

Applications will be accepted on a rolling basis.

Selected applicants will be notified by a member of the VelocityTX team with additional details about the roundtable sessions along with participant requirements and commitment.

Incubator Program

The Incubator Program is designed to scale early-stage bioscience companies by providing long-term support and includes office and meeting space, access to industry experts, mentors, and more.

CEO Roundtable

The CEO Roundtable is an exclusive membership program that brings together executives from non-competing bioscience and healthcare companies to foster innovation, collaboration, and connections.